NCT03464695

Brief Summary

The aim of the study is to examine if automated oxygen delivery with O2matic is better than manually controlled oxygen therapy for patients admitted to hospital with an exacerbation in Chronic Obstructive Pulmonary Disease (COPD). O2matic is a closed -loop system based on continuous non-invasive measurement of pulse and oxygen-saturation that is processed in an algorithm that controls the flow of oxygen to the patient. The primary hypothesis is that O2matic increases time within acceptable oxygen-saturation interval. Secondary hypotheses are that O2matic compared to manual control reduces time with severe hypoxia (SpO2 \< 85 %), hypoxi (SpO2 below intended interval) and hyperoxia (SpO2 above intended interval).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 14, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

May 7, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 8, 2018

Completed
Last Updated

January 8, 2019

Status Verified

January 1, 2019

Enrollment Period

3 months

First QC Date

March 2, 2018

Last Update Submit

January 6, 2019

Conditions

Keywords

closed-loopoxygen treatment

Outcome Measures

Primary Outcomes (1)

  • Time within SpO2-interval

    Fraction of time where SpO2 is kept within desired interval (e.g. 88-92 %) relative to time with SpO2-signal.

    4 hours

Secondary Outcomes (3)

  • Time with severe hypoxia

    4 hours

  • Time with hypoxia

    4 hours

  • Time with hyperoxia

    4 hours

Study Arms (2)

O2matic

ACTIVE COMPARATOR

Oxygen administered by O2matic. Automatic adjustment based on continuous measurement of SpO2.

Device: O2matic

Manual

NO INTERVENTION

Oxygen administered by manual control based on nurse's intermittent measurement of SpO2.

Interventions

O2maticDEVICE

Continous measurement of SpO2 during an admission with COPD, and closed-loop control of oxygen-delivery to maintain SpO2 within a target interval.

O2matic

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD verified by FEV1/FVC \< 0,70
  • Admission due to exacerbation in COPD
  • COPD exacerbation and pneumonia can be included
  • Duration of admission \> 48 hours
  • Cognitively able to participate in the study
  • Willing to participate and give informed consent.

You may not qualify if:

  • Need or anticipated need for mechanical ventilation (except intermittent CPAP)
  • Major co-morbidities (cancer, heart disease, thromboembolic disease, uncontrolled diabetes)
  • Asthma or other respiratory condition requiring higher SpO2 than normal for COPD- patients
  • Pregnancy
  • Acute thromboembolic disease (\< 2 weeks)
  • Cognitive barriers for participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Gentofte University Hospital

Hellerup, 2900, Denmark

Location

Hvidovre University Hospital

Hvidovre, 2650, Denmark

Location

Related Publications (7)

  • Claure N, Bancalari E. Closed-loop control of inspired oxygen in premature infants. Semin Fetal Neonatal Med. 2015 Jun;20(3):198-204. doi: 10.1016/j.siny.2015.02.003. Epub 2015 Mar 12.

    PMID: 25773271BACKGROUND
  • Johannigman JA, Branson R, Lecroy D, Beck G. Autonomous control of inspired oxygen concentration during mechanical ventilation of the critically injured trauma patient. J Trauma. 2009 Feb;66(2):386-92. doi: 10.1097/TA.0b013e318197a4bb.

    PMID: 19204511BACKGROUND
  • L'Her E, Dias P, Gouillou M, Riou A, Souquiere L, Paleiron N, Archambault P, Bouchard PA, Lellouche F. Automatic versus manual oxygen administration in the emergency department. Eur Respir J. 2017 Jul 20;50(1):1602552. doi: 10.1183/13993003.02552-2016. Print 2017 Jul.

    PMID: 28729473BACKGROUND
  • Lellouche F, Bouchard PA, Roberge M, Simard S, L'Her E, Maltais F, Lacasse Y. Automated oxygen titration and weaning with FreeO2 in patients with acute exacerbation of COPD: a pilot randomized trial. Int J Chron Obstruct Pulmon Dis. 2016 Aug 24;11:1983-90. doi: 10.2147/COPD.S112820. eCollection 2016.

    PMID: 27601891BACKGROUND
  • Lellouche F, L'Her E, Bouchard PA, Brouillard C, Maltais F. Automatic Oxygen Titration During Walking in Subjects With COPD: A Randomized Crossover Controlled Study. Respir Care. 2016 Nov;61(11):1456-1464. doi: 10.4187/respcare.04406. Epub 2016 Oct 18.

    PMID: 27794080BACKGROUND
  • Rice KL, Schmidt MF, Buan JS, Lebahn F, Schwarzock TK. AccuO2 oximetry-driven oxygen-conserving device versus fixed-dose oxygen devices in stable COPD patients. Respir Care. 2011 Dec;56(12):1901-5.

    PMID: 22288082BACKGROUND
  • Hansen EF, Hove JD, Bech CS, Jensen JS, Kallemose T, Vestbo J. Automated oxygen control with O2matic(R) during admission with exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2018 Dec 14;13:3997-4003. doi: 10.2147/COPD.S183762. eCollection 2018.

Related Links

MeSH Terms

Conditions

HypoxiaHyperoxiaRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsRespiration DisordersRespiratory Tract Diseases

Study Officials

  • Jørgen Vestbo, DMSc

    Manchester University Hospital

    STUDY CHAIR
  • Ejvind Frausing Hansen, MD

    Hvidovre University Hospital, Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician

Study Record Dates

First Submitted

March 2, 2018

First Posted

March 14, 2018

Study Start

May 7, 2018

Primary Completion

August 8, 2018

Study Completion

August 8, 2018

Last Updated

January 8, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations